U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07199452) titled 'A Study of Rifabutin and MK-4646 in Healthy Participants (MK-4646-004)' on Sept. 22.
Brief Summary: Researchers have designed a new study medicine called MK-4646 as a new way to treat human immunodeficiency virus (HIV). Rifabutin is a medication used to treat tuberculosis (TB).
Researchers want to learn about MK-4646 when taken at the same time as Rifabutin.
They want to:
Measure a person's blood to find out if the amount of MK-4646 in the blood is the same when MK-4646 is taken alone or with Rifabutin Learn about the safety of MK-4646 when taken alone or with Rifabutin and if people tolerate it
Study Start Date: Oct. 28
Study T...